SHIFT AI Newsroom · GLOBAL
Orforglipron Research Explores Weight Loss Maintenance
Study investigates whether oral orforglipron can maintain weight loss after stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment
Researchers are investigating whether oral orforglipron can maintain weight loss in patients who have stopped taking glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment. The study's findings could have implications for patients in the UK who have achieved weight loss with GLP-1 RA treatment and are looking for ways to maintain it.
What this means in the UK
The study's findings could have implications for UK patients who have achieved weight loss with GLP-1 RA treatment and are looking for ways to maintain it
Known facts
- Orforglipron is being researched as a potential treatment to maintain weight loss after GLP-1 RA discontinuation